DEALTALK-Biotech takeover interest more fad than fashion
July 19, 2013 at 00:59 AM EDT
July 19 (Reuters) - Investors betting on a wave of big biotechnology deals following Amgen Inc's $10 billion bid for Onyx Pharmaceuticals Inc may well be disappointed.
